X

Translational Bytes

Translational Bytes


Apr16 Understanding the Pharmacokinetics of Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Using Physiologically Based Pharmacokinetic Models

The use of cannabis has rapidly increased over the past decade. Understanding how the body processes cannabinoids like THC and CBD is critical for optimizing their safety and medical use. Both compounds undergo first-pass metabolism, primarily through cytochrome P450 (CYP) enzymes and UDP-glucurono...
Read More..

Mar25 Detecting NAFLD and NASH via Algorithm

Identification and stratification of patients with under-recognized metabolic disease is critical in addressing the Nonalcoholic Fatty Liver Disease (NAFLD)* public health crisis. Reliance on frontline healthcare recognition alone may contribute to delays in treatment, monitoring, and referrals for...
Read More..

Mar17 Common Language for Cancer Detection Technology!

Early detection has been instrumental in reducing cancer mortality rates. With that, there has been a surge in the development of single-cancer detection (SCD) and multi-cancer detection (MCD) testing technology. In a rapidly evolving field, ensuring that all stakeholders are using consistent langu...
Read More..

Feb20 What If You Could Experiment on Your Electronic Self?

What is a digital twin? Imagine having a digital mechanistic model-based replica of a patient, enabling you to simulate various treatments and predict their outcomes – your “digital twin.” This powerful concept allows for personalized medicine by mirroring the patient's unique biology and ch...
Read More..

Feb06 Application of Modeling and Simulation for In Vivo CAR-Ts to Inform Dose and Regimen Selection

In vivo programming of endogenous T-cells to induce transient CAR-expression ( in vivo CAR-Ts) could be a potential alternative to exogenously administered autologous and allogeneic cell therapies, which inherently possess several limitations such as logistical/financial constraints and graft v...
Read More..

Jan28 Why do Diabetic Participants Enroll in Clinical Trials?

Decentralised clinical trial (DCT) approaches move all or part of a trial’s activities to the participant’s direct environment by using digital technologies and other operational innovations. Working with people living with type 2 diabetes from three European countries, we uncovered “What motivate...
Read More..

Jan21 CTS: Ringing in 2025, and Looking Back on a Strong 2024!

Wishing you a new year filled with breakthroughs in translational science! At Clinical and Translational Science ( CTS ), we hope you had a wonderful and relaxing holiday season with your family and friends, and wish you a happy, healthy, and successful 2025.
Read More..

Jan07 Electronic Health Record Big Data: Massive Responsibility, Little Oversight – A Learning Tale

As the size of the data platforms grows and their relative ease of use improves, so does the potential for error or misinterpretation. It becomes crucial to consider the problems we try to address and whether they are reasonable for the available data and structure. It is critical to distinguish st...
Read More..

Dec19 Cluster Gauss-Newton Method: A Way to Improve PBPK Parameter Estimation?

DPP-4 is an endopeptidase widely expressed in organs and tissues, regulating blood glucose by degrading incretin hormones. DPP-4 has two forms: transmembrane DPP-4 (tDPP-4), found on cell membranes, and soluble DPP-4 (sDPP-4), produced by the shedding of tDPP-4 into plasma. tDPP-4 predominates, es...
Read More..

Dec11 Impact of Inflammation of Observed CYP2C19 Metabolism Phenotype

Voriconazole is used to prevent and treat fungal infections following allogeneic hematopoietic stem cell transplantation. CYP2C19 converts it into inactive metabolites. The CYP2C19 gene is genetically polymorphic resulting in five distinct metabolizers phenotypes: poor (2%), intermediate (IM, 23%),...
Read More..
Photo Gallery
Recent News
  • Understanding the Pharmacokinetics of Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Using Physiologically Based Pharmacokinetic Models
    April 16, 2025
  • ASCPT Adviser: April 2025
    April 03, 2025
  • I am ASCPT: Daisy Zhu
    April 01, 2025
Contact Us